Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiangdong Cheng

Showing results (141-150 of 155) with videos related to

Pageof 16
Sort By:
Cancer Cell|July 15, 2026
Perioperative tislelizumab plus chemotherapy for locally advanced gastric cancer: A randomized, prospective phase 2 trialZhiyuan Xu, Can Hu, Litao Yang, et al.
Cancer Letters|June 14, 2024
Development and evaluation of a risk prediction tool for risk-adapted screening of colorectal cancer in ChinaDong Hang, Dianjianyi Sun, Lingbin Du, et al.
Cancer Research|June 18, 2026
PARG Governs a PARylation-Ubiquitination Toggle that Stabilizes RAD51AP1 to Drive Homologous Recombination-Mediated ChemoresistanceHanyi He, Yangchan Hu, Ye Lu, et al.
Iscience|May 1, 2026
Multi-institutional assessment of HER2 immunohistochemistry in gastric and esophagogastric junction cancerXiu Zhu, Lan Yang, Yangqin Zheng, et al.
Nature Communications|October 30, 2025
Common genetic variation influencing the human lung imaging phenotypesMeng Zhu, Lingbin Du, Lei Shi, et al.
BMJ Open|December 3, 2025
Laparoscopic versus open distal gastrectomy with D2 lymphadenectomy following neoadjuvant chemotherapy for locally advanced gastric cancer (CLASS-03b): protocol for a multicentre, randomised, controlled, non-inferiority trialYidi Liang, Xiaolong Chen, Weihan Zhang, et al.
Gut|July 17, 2023
Efficient plasma metabolic fingerprinting as a novel tool for diagnosis and prognosis of gastric cancer: a large-scale, multicentre studyZhiyuan Xu, Yida Huang, Can Hu, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 14, 2025
Asian consensus on normothermic intraperitoneal and systemic treatment for gastric cancer with peritoneal metastasisZhenggang Zhu, Joji Kitayama, Hyung-Ho Kim, et al.
Nature Communications|August 24, 2024
METI: deep profiling of tumor ecosystems by integrating cell morphology and spatial transcriptomicsJiahui Jiang, Yunhe Liu, Jiangjiang Qin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2024
Pathologic Response of Phase III Study: Perioperative Camrelizumab Plus Rivoceranib and Chemotherapy Versus Chemotherapy for Locally Advanced Gastric Cancer (DRAGON IV/CAP 05)Chen Li, Yantao Tian, Yanan Zheng, et al.
Pageof 16

Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
Cancer Cell|July 15, 2026
Perioperative tislelizumab plus chemotherapy for locally advanced gastric cancer: A randomized, prospective phase 2 trialZhiyuan Xu, Can Hu, Litao Yang, et al.
Cancer Letters|June 14, 2024
Development and evaluation of a risk prediction tool for risk-adapted screening of colorectal cancer in ChinaDong Hang, Dianjianyi Sun, Lingbin Du, et al.
Cancer Research|June 18, 2026
PARG Governs a PARylation-Ubiquitination Toggle that Stabilizes RAD51AP1 to Drive Homologous Recombination-Mediated ChemoresistanceHanyi He, Yangchan Hu, Ye Lu, et al.
Iscience|May 1, 2026
Multi-institutional assessment of HER2 immunohistochemistry in gastric and esophagogastric junction cancerXiu Zhu, Lan Yang, Yangqin Zheng, et al.
Nature Communications|October 30, 2025
Common genetic variation influencing the human lung imaging phenotypesMeng Zhu, Lingbin Du, Lei Shi, et al.
BMJ Open|December 3, 2025
Laparoscopic versus open distal gastrectomy with D2 lymphadenectomy following neoadjuvant chemotherapy for locally advanced gastric cancer (CLASS-03b): protocol for a multicentre, randomised, controlled, non-inferiority trialYidi Liang, Xiaolong Chen, Weihan Zhang, et al.
Gut|July 17, 2023
Efficient plasma metabolic fingerprinting as a novel tool for diagnosis and prognosis of gastric cancer: a large-scale, multicentre studyZhiyuan Xu, Yida Huang, Can Hu, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 14, 2025
Asian consensus on normothermic intraperitoneal and systemic treatment for gastric cancer with peritoneal metastasisZhenggang Zhu, Joji Kitayama, Hyung-Ho Kim, et al.
Nature Communications|August 24, 2024
METI: deep profiling of tumor ecosystems by integrating cell morphology and spatial transcriptomicsJiahui Jiang, Yunhe Liu, Jiangjiang Qin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2024
Pathologic Response of Phase III Study: Perioperative Camrelizumab Plus Rivoceranib and Chemotherapy Versus Chemotherapy for Locally Advanced Gastric Cancer (DRAGON IV/CAP 05)Chen Li, Yantao Tian, Yanan Zheng, et al.
Pageof 16